Precision Vaccinations News
Search
Inline CSS
Clinical Trials
Lab Tests
Subscribe
Trials
Labs
Subscribe
Home
Dengue
Flu
Measles
RSV
STD
Travel
Vaccines
Bladder Cancer
Fact checked by
Robert Carlson, MD
Apr 23
3 min read
US FDA Approves IL-15 Superagonist for Treating Bladder Cancer
ImmunityBio Anktiva N-803 Plus BCG vaccination is an FDA approved bladder cancer therapy
Bladder Cancer
Fact checked by
Robert Carlson, MD
Feb 5
4 min read
Bladder Cancer Vaccine Therapy Offers Favorable Risk-Benefit Ratio
N-803 plus BCG bladder cancer vaccine therapy candidate has Prescription Drug User Fee Act date of April 23, 2024
Bladder Cancer
Fact checked by
Holly Lutmer PharmD
Oct 23
5 min read
Non-Muscle-Invasive Bladder Cancer Vaccine Candidate Competes Resubmission to US FDA
Anktiva N-803 is a first-in-class IL-15 superagonist plus BCG vaccine
Bladder Cancer
Fact checked by
Robert Carlson, MD
Jan 9
4 min read
Bladder Cancer Treatment Innovates in the Right Direction
N-803 Plus BCG in Patients with Bladder Cancer found effective
Bladder Cancer